Brief: ZYUS Life Sciences Receives Cannabis Drug License From Health Canada
04/06/2024 12:33
June 4 (Reuters) - ZYUS Life Sciences Corp ZYUS.V :
* ZYUS LIFE SCIENCES RECEIVES CANNABIS DRUG LICENSE FROM
HEALTH
CANADA
Source text for Eikon: ID:nBwbLXdMGa
Further company coverage: ZYUS.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zyus Life Sciences
See all newsBrief: Zyus Life Sciences Announces Strategic Realignment To Prioritize Drug Development
Brief: Zyus Life Sciences Reports Preliminary Results From Ongoing Phase 2A Utopia-1 Trial
Brief: ZYUS Life Sciences Provides Update On Clinical Trial Progress And Unit Private Placement
Brief: Zyus Closes First Tranche Of Unit Offering, Issues Warrants Under Loan Agreements And Note Amendment
Brief: Zyus Life Sciences Corporation Announces Closing Of Additional Secured Loan